Biology of Cox-2: An Application in Cancer Therapeutics
Journal:
Current Drug Targets
Volume:
12
Page:
1082-1093
Author(s):
Zakir Khan, Noor Khan, Ram P. Tiwari, Nand K. Sah, GBKS Prasad and Prakash S. Bisen
Gene Therapy and Targeted Toxins for Glioma
Journal:
Current Gene Therapy
Volume:
11
Page:
155-180
Author(s):
Maria G. Castro, Marianela Candolfi, Kurt M. Kroeger, Gwendalyn D. King, James F. Curtin, Kader Yagiz, Yohei Mineharu, Hikmat Assi, Mia Wibowo, A. K.M. Ghulam Muhammad, David Foulad, Mariana Puntel and Pedro R. Lowenstein
Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2686-2714
Author(s):
S. J. Shuttleworth, F. A. Silva, A. R.L. Cecil, C. D. Tomassi, T. J. Hill, F. I. Raynaud, P. A. Clarke and P. Workman
Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2836-2847
Author(s):
E. Crespan, E. Zucca and G. Maga
Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2913-2920
Author(s):
F. Condorelli, E. Stec-Martyna, J. Zaborowska, L. Felli, I. Gnemmi, M. Ponassi and C. Rosano
Approaches to Gastrointestinal Cytoprotection: From Isolated Cells, Via Animal Experiments to Healthy Human Subjects and Patients with Different Gastrointestinal Disorders
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
1556-1572
Author(s):
Gyula Mozsik, Imre L. Szabo and Jozsef Czimmer
Antibacterial Peptides and Gastrointestinal Diseases
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
1583-1586
Author(s):
Clover C. M. Wong, Lin Zhang, Shun X. Ren, Jing Shen, Ruby L. Y. Chan and Chi H. Cho
The Urokinase Receptor Interactome
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
1874-1889
Author(s):
Gabriele Eden, Marco Archinti, Federico Furlan, Ronan Murphy and Bernard Degryse
Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
1890-1910
Author(s):
Martin C. Boonstra, Hein W. Verspaget, Sjam Ganesh, Frank J.G.M. Kubben, Alexander L. Vahrmeijer, Cornelis J.H. van de Velde, Peter J.K. Kuppen, Paul H.A. Quax and Cornelis F.M. Sier
The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
1944-1961
Author(s):
Maria Vincenza Carriero and Maria Patrizia Stoppelli